Jing Xiao

发表

CXCL12 and IL7R as Novel Therapeutic Targets for Liver Hepatocellular Carcinoma Are Correlated With Somatic Mutations and the Tumor Immunological Microenvironment

Qianshan Ding, Shuai Liu, Ligong Lu, 2020, Frontiers in Oncology.

Development of a prognostic model based on immunogenomic landscape analysis of hepatocellular carcinoma

Fujun Zhang, Meixiao Zhan, Xu He, 2021 .

Temperature and salt responsive zwitterionic polysulfamide-based nanogels with surface regeneration ability and controlled drug release

Ligong Lu, Meixiao Zhan, Shaojun Peng, 2019, Polymer Chemistry.

Inhibition of the transcription factor ZNF281 by SUFU to suppress tumor cell migration

Meixiao Zhan, S. Yuan, Zizhang Zhou, 2022, Cell Death & Differentiation.

Distinct binding pattern of EZH2 and JARID2 on RNAs and DNAs in hepatocellular carcinoma development

Yu Zhang, Meixiao Zhan, Xu He, 2022, Frontiers in Oncology.

Activation of MET promotes resistance to sorafenib in hepatocellular carcinoma cells via the AKT/ERK1/2-EGR1 pathway

Minshan Chen, Meixiao Zhan, Xu He, 2019, Artificial cells, nanomedicine, and biotechnology.

Injectable nano-composite hydrogels based on hyaluronic acid-chitosan derivatives for simultaneous photothermal-chemo therapy of cancer with anti-inflammatory capacity.

Yu Fan, Ligong Lu, Weizhong Yuan, 2023, Carbohydrate polymers.

Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway

Xun Ai, X. Hou, Ligong Lu, 2018, Front. Pharmacol..

DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.

X. Hou, Meixiao Zhan, S. Yuan, 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

MiR-135b promotes HCC tumorigenesis through a positive-feedback loop.

Ligong Lu, Meixiao Zhan, Xu He, 2020, Biochemical and biophysical research communications.

GPR27 Regulates Hepatocellular Carcinoma Progression via MAPK/ERK Pathway

Hong Wang, S. Yuan, Jing Xiao, 2022, Cancer management and research.

LncRNA HOXA11‐AS promotes hepatocellular carcinoma progression by repressing miR‐214‐3p

Haihe Wang, Ligong Lu, Meixiao Zhan, 2018, Journal of cellular and molecular medicine.

Bidirectional modulation of insulin action by reactive oxygen species in 3T3-L1 adipocytes

L. Luo, Ligong Lu, Meixiao Zhan, 2018, Molecular medicine reports.

LncRNA PCAT6 increased cholangiocarcinoma cell proliferation and invasion via modulating miR-330-5p.

Ligong Lu, Meixiao Zhan, Xu He, 2019, American journal of translational research.

Fabrication of thermoresponsive magnetic micelles from amphiphilic poly(phenyl isocyanide) and Fe3O4 nanoparticles for controlled drug release and synergistic thermochemotherapy

Weizhong Yuan, Meixiao Zhan, Xu He, 2021 .

Circulating tumor DNA as a potential prognostic and predictive biomarker during interventional therapy of unresectable primary liver cancer.

X. Yi, Y. Guan, Ligong Lu, 2020, Journal of gastrointestinal oncology.

SH3BGRL Suppresses Liver Tumor Progression through Enhanced ATG5-Dependent Autophagy

Bin Liu, Haihe Wang, Jing Xiao, 2023, Journal of oncology.

Review immune response of targeting CD39 in cancer

Xian-Yang Li, Guokai Chen, Jiacheng Bi, 2023, Biomarker Research.

Lysyl oxidase-like 3 restrains mitochondrial ferroptosis to promote liver cancer chemoresistance by stabilizing dihydroorotate dehydrogenase

Ligong Lu, Hua Yu, Meixiao Zhan, 2023, Nature communications.